Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Folsom AR et al. - Race/ethnicity, sex, and to a lesser degree LDL-cholesterol and cholesterol-lowering therapy, but few other risk factors, were correlated with markers of cellular activation in this population-based study.

Related Articles

Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
Current Medical Research and Opinion, 10/22/09    Relevance Score: 92%

Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09    Relevance Score: 90%

Total cholesterol and LDL levels decrease before rheumatoid arthritis
Annals of Rheumatic Diseases, 11/10/09    Relevance Score: 89%

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation
Breast Cancer Research and Treatment, 11/04/09    Relevance Score: 88%

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Vascular Health and Risk Management, 11/03/09    Relevance Score: 88%

Today in Atherosclerosis/Lipids...keeping you current

Functional foods for dyslipidaemia and cardiovascular risk prevention
Nutrition Research Reviews, 12/15/09

Optimizing Vascular Risk Reduction in the Stroke Patient with Atherothrombotic Disease
Medical Principles and Practice, 12/15/09

Impact of progressive resistance training on lipids and lipoproteins in adults: Another look at a meta-analysis using prediction intervals
Preventive Medicine, 12/15/09